Skip to content

The Third Survey of Prescription Pattern of Psychotropic Drugs in China

The Third Survey on China Psychotropic Prescription for Schizophrenia, Depression and Bipolar Disorder

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01668810
Enrollment
7000
Registered
2012-08-20
Start date
2012-07-31
Completion date
2013-07-31
Last updated
2012-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prescription

Keywords

prescription, schizophrenia, depression, bipolar disorder

Brief summary

The investigators aimed to examine the psychotropic prescription pattern in China.

Interventions

None listed

Sponsors

Xian-Janssen Pharmaceutical Ltd.
CollaboratorINDUSTRY
Peking University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

aged 18-65, inpatient or outpatient, Patient must be willing and able to give written informed consent,the patient suffers from schizophrenia or depression or bipolar disorder -

Exclusion criteria

aged\<18or aged\>65 \-

Countries

China

Contacts

Primary ContactYun-Ai Su, Phd.
suyunai@gmail.com8610-82801960

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026